Physician profile
Katherine Williams
NPI 1902250475
$4,063.74
in general payments reported to CMS, 2019-2025
22 companies · $314 in 2025
The $314 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $215 · 2022: $1,175 · 2023: $1,842 · 2024: $517 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,882 · Travel and Lodging: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,881.82 |
| Travel and Lodging | $791.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,488.99 | 2021-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $1,294.30 | 2022-2023 | Synchromedii, Intellis Adaptivestim |
| Abbvie INC. | $390.48 | 2021-2025 | Ubrelvy, Qulipta |
| Vertos Medical, INC. | $140.06 | 2021-2022 | |
| Amgen INC. | $119.64 | 2021-2022 | |
| Pfizer INC. | $85.41 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $78.51 | 2024-2025 | |
| Allergan, INC. | $76.17 | 2022 | |
| Tersera Therapeutics LLC | $64.44 | 2024-2025 | Prialt |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.42 | 2021-2023 | Relistor |
| Lilly USA, LLC | $40.39 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $31.01 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.06 | 2023 | Seglentis |
| Si-Bone, INC. | $22.69 | 2022 | |
| Valinor Pharma, LLC | $20.71 | 2025 | Movantik |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $20.02 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $19.96 | 2025 | Dysport |
| Spinal Simplicity, LLC | $18.11 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.78 | 2025 | Belbuca |
| Merck Sharp & Dohme LLC | $16.76 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.22 | 2022 | |
| Boston Scientific Corporation | $13.61 | 2025 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.